Drug development for glioma: are we repeating the same mistakes?

Lancet Oncol. 2019 Jan;20(1):10-12. doi: 10.1016/S1470-2045(18)30827-1. Epub 2018 Dec 3.
No abstract available

Publication types

  • Comment

MeSH terms

  • Drug Development
  • Glioblastoma*
  • Glioma*
  • Humans
  • Lomustine
  • Phenylurea Compounds
  • Pyridines

Substances

  • Phenylurea Compounds
  • Pyridines
  • regorafenib
  • Lomustine

Associated data

  • ClinicalTrials.gov/NCT02017717